No Short-Term Cancer Risk From Recalled Heart Med Valsartan: Study

THURSDAY, Sept. 13, 2018 -- People who took recalled blood pressure drugs containing a carcinogen do not appear to have a markedly increased short-term risk of cancer, a new study reports. Doctors are reluctant to say they're fully in the clear,...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

LUNG cancer symptoms include a cough the won ’t go away, unexplained weight loss and severe chest pain. But you could also be at risk of deadly lung tumour signs if your eyes are a distinctive colour.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
While medicine transforms cancer into a chronic disease with which patients can live for an extended period of time, financial toxicity threatens to turn chronic, too.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Health Insurance and Managed Care Drugs (Pharmaceuticals) Bankruptcies Cancer Source Type: news
Elisa Boldrin, Sandro Malacrida, Enrica Rumiato, Giorgio Battaglia, Alberto Ruol, Alberto Amadori, Daniela Saggioro
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, Won Fen Wong, Gautam Sethi, Chung Yeng Looi
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Vincenzo Ingangi, Michele Minopoli, Concetta Ragone, Maria Letizia Motti, Maria Vincenza Carriero
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Source: Lung Cancer - Category: Cancer & Oncology Source Type: research
Source: Lung Cancer - Category: Cancer & Oncology Source Type: research
A new study from the CDC found cases of women positive for HPV types 16 and 18 - responsible for about 70% of cervical cancers worldwide - fell by more than 30% from 2008 to 2014.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
In HIV-infected patients with a variety of advanced cancers, immune-checkpoint inhibitors (ICIs) appear to be effective and add no new risks, according to a new systematic review.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news
The company said in a regulatory filing that it had received subpoenas from the Justice Department and the Securities and Exchange Commission related to its talc-based products.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Hazardous and Toxic Substances Regulation and Deregulation of Industry Drugs (Pharmaceuticals) Asbestos Johnson & Justice Department Securities and Exchange Commission Ovarian Cancer Suits and Litigation (Civil) Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Diovan | General Medicine | Heart | Study